ET-1 as a marker of microvascular EC dysfunction showed a significant decrease in plasma concentrations with mean levels being in the normal range, while vWF:AG levels, representing endothelial damage, remained elevated in the majority of patients at 18 months after acute COVID-19. The gene discussed is RENBP; the disease is COVID-19.